Xuliang Wang

488 total citations
9 papers, 301 citations indexed

About

Xuliang Wang is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Xuliang Wang has authored 9 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in Xuliang Wang's work include RNA modifications and cancer (2 papers), Epigenetics and DNA Methylation (2 papers) and Cancer-related molecular mechanisms research (2 papers). Xuliang Wang is often cited by papers focused on RNA modifications and cancer (2 papers), Epigenetics and DNA Methylation (2 papers) and Cancer-related molecular mechanisms research (2 papers). Xuliang Wang collaborates with scholars based in China, Vietnam and United States. Xuliang Wang's co-authors include Jiahui Li, Zhen-Shun Gan, Yizhen Wang, Huahua Du, Qianqian Wang, Xing Rong, Maoping Chu, Rongzhou Wu, Ping Li and Tingting Wu and has published in prestigious journals such as Life Sciences, Molecular Therapy and Frontiers in Physiology.

In The Last Decade

Xuliang Wang

9 papers receiving 297 citations

Peers

Xuliang Wang
Comparison fields: 5 of 69
  • Molecular Biology 184
  • Cancer Research 85
  • Immunology 63
  • Cardiology and Cardiovascular Medicine 26
  • Pulmonary and Respiratory Medicine 25
Replace Tatiana Konovalova with:
Tatiana Konovalova Germany
Zhenghua Su China
Linsey J. F. Peters Netherlands
William L. Willis United States
Ling Lin China
Clemens Gutmann United Kingdom
Yiping Hu China
Hui Han China
Jiakai Zhang China
Tatiana Konovalova Germany View profile →
Citations per field, relative to Xuliang Wang
Xuliang Wang · 1×
Citations per year, relative to Xuliang Wang
Xuliang Wang · 1×

Countries citing papers authored by Xuliang Wang

Since Specialization
Citations

This map shows the geographic impact of Xuliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuliang Wang more than expected).

Fields of papers citing papers by Xuliang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuliang Wang. The network helps show where Xuliang Wang may publish in the future.

Co-authorship network of co-authors of Xuliang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuliang Wang. A scholar is included among the top collaborators of Xuliang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuliang Wang. Xuliang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
# Work Indexed citations
1 29
2 7
3 46
4 4
5 2
6 24
7 74
8 109
9 6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026